Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Investors make a beeline for WuXi AppTec shares

    By Cai Xiao | China Daily | Updated: 2018-05-26 11:51
    Share
    Share - WeChat
    Interior view of the headquarters of WuXi Biologics' parent firm, WuXi AppTec, in Shanghai, April 23, 2018. [Photo/IC]

    Leading contract research outsourcing provider WuXi AppTec saw its A-share price jump by the daily limit of 10 percent again on Friday after 13 consecutive trading days of gains to 107.36 yuan ($16.80).

    The market capitalization of the newly listed company totaled 111.9 billion yuan on Friday, ranked fifth by market capitalization among A-share listed pharmaceutical and biotechnology companies.

    Jiangsu Hengrui Medicine Co Ltd, Kangmei Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd were the other four firms.

    WuXi AppTec became the most profitable new share as investors could earn about 86,000 yuan for every 1,000 shares based on Friday's stock performance.

    The trading volume of WuXi AppTec totaled 272 million yuan on Friday, compared with 57.6 million yuan on Thursday.

    WuXi AppTec released a statement on Friday afternoon to remind investors of paying attention to the company's operating risks after 14 consecutive trading days of gains.

    "The nation levied no tariffs on imported anti-cancer drugs, as well as imported potency drugs, which also forced domestic drug manufacturers to upgrade their products, creating great opportunities for contract research organizations, with WuXi AppTec taking a lead.

    "Besides, as the market is opening up, there are limited enterprises that are able to offer qualified products, this explains why the company is favored by investors," said Chen Qiaoshan, senior medical analyst at Beijing-based internet consultancy Analysys.

    WuXi AppTech, formerly known as WuXi PharmaTech (Cayman) Inc, was listed at the New York Stock Exchange in 2007 and went private in 2015. WuXi PharmaTech (Cayman) Inc was divided into three companies then: Pharmaceutical Co Ltd listed at China's new third board in 2015, Wuxin Biologics went public in Hong Kong in 2017 and WuXi AppTech, which was listed in May.

    Zheng Yiran contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    天堂亚洲国产中文在线| 无码人妻精品一区二区在线视频| 八戒理论片午影院无码爱恋| 亚洲av无码天堂一区二区三区 | 无码AV波多野结衣久久| 日韩中文在线视频| 人妻少妇无码视频在线| 无码精品久久久天天影视| 无码人妻精品一区二区蜜桃网站| 亚洲国产综合无码一区二区二三区 | 欧美日韩中文字幕在线看| 国产自无码视频在线观看 | 久久av无码专区亚洲av桃花岛 | 无码人妻精品一区二区蜜桃网站| 中文字幕亚洲码在线| yy111111电影院少妇影院无码| 亚洲精品无码午夜福利中文字幕 | 亚洲福利中文字幕在线网址 | 久久99中文字幕久久| 99在线精品国自产拍中文字幕| 2021国产毛片无码视频| 色情无码WWW视频无码区小黄鸭| 国产激情无码一区二区三区| 亚洲色无码播放| 影音先锋中文无码一区| 无码福利一区二区三区| 四虎影视无码永久免费| 中文字幕国产91| 免费无码又爽又刺激高潮软件| 亚洲国产人成中文幕一级二级| 欧美一级一区二区中文字幕| 最近2022中文字幕免费视频| 最近2019中文字幕| 最近最新中文字幕完整版| 国产欧美日韩中文字幕| 日韩乱码人妻无码中文视频| 亚洲日韩欧美国产中文| 在人线AV无码免费高潮喷水| 亚洲精品无码久久一线| 日韩精品专区AV无码| 国产强伦姧在线观看无码|